Antimicrobiology in Epidemiology

Antimicrobial resistance has become a serious healthcare problem, with high resistance rates of most common bacteria to clinically important antimicrobial agents. Resistance has emerged to even the newer, almost potent antimicrobial agents. Methicillin-resistant S. aureus, ESBL-producing Enterobacteriaceae and carbapenem-resistant Acinetobacter baumannii represent more than 50% of microbial isolates. Furthermore, bacterial resistance to fluoroquinolones, macrolides and third-generation cephalosporins is of serious concern. The molecular epidemiology and resistance mechanisms of the antimicrobial strains exhibited regional specificity, as well as the influence of dissemination of international clonal complexes.


    Related Conference of Antimicrobiology in Epidemiology

    November 19-20, 2025

    6th International Conference on Vaccine Research

    Tokyo, Japan
    March 16-17, 2026

    8th World Congress on Vaccine and Immunology

    Paris, France
    September 21-22, 2026

    44th Euro Global Summit and Expo on Vaccines & Vaccination

    Barcelona, Spain

    Antimicrobiology in Epidemiology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in